These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9292918)

  • 1. Improvement of the biological performance of oral anticoagulant drugs. 1. Warfarin.
    Ammar HO; Ghorab M; el-Nahhas SA; Makram TS
    Pharmazie; 1997 Aug; 52(8):627-31. PubMed ID: 9292918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of oral anticoagulants with methyl xanthines.
    Ammar HO; Ghorab M; el-Nahhas SA; Makram TS
    Pharmazie; 1997 Dec; 52(12):946-50. PubMed ID: 9442558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in pharmacokinetics of oral warfarin in rats.
    Zhu X; Shin WG
    Biopharm Drug Dispos; 2005 May; 26(4):147-50. PubMed ID: 15776499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of ruminal degradation, oral bioavailability, and toxic effects of anticoagulant rodenticides in sheep.
    Berny PJ; de Oliveira LA; Videmann B; Rossi S
    Am J Vet Res; 2006 Feb; 67(2):363-71. PubMed ID: 16454646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
    Simonson SG; Martin PD; Mitchell PD; Lasseter K; Gibson G; Schneck DW
    J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
    Wittkowsky AK
    Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
    J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB; Kell S; Simon M; Vargas R
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
    Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
    Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system.
    Hoffart V; Lamprecht A; Maincent P; Lecompte T; Vigneron C; Ubrich N
    J Control Release; 2006 Jun; 113(1):38-42. PubMed ID: 16697485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of dissolution rate of mitotane and warfarin prepared by using microemulsion systems.
    Lin YH; Chen YS; Wu TC; Chen LJ
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):366-72. PubMed ID: 21478000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers.
    Friedrich H; Fussnegger B; Kolter K; Bodmeier R
    Eur J Pharm Biopharm; 2006 Feb; 62(2):171-7. PubMed ID: 16275049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of subcutaneous forms in the improvement of pharmacokinetic profile of warfarin.
    Scala-Bertola J; Javot L; Camargo JA; Bonneaux F; Lecompte T; Maincent P; Sapin A
    Int J Pharm; 2012 Jul; 431(1-2):33-8. PubMed ID: 22531852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectroscopic evidence for the presence of the cyclic hemiketal form of warfarin in aqueous solution: consequences for bioavailability.
    Rosengren AM; Karlsson BC
    Biochem Biophys Res Commun; 2011 Apr; 407(2):318-20. PubMed ID: 21382344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.